Operationalizing the Patient Voice for Long-Term Protocol Planning and Execution
This case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how patient engagement in larger corporations can be a long-term growth driver and not just a short-term cost.
Summary:
This podcast from the 2024 DPHARM conference showcases the value of patient engagement as a core strategic investment by focusing on the connection between patient engagement and tangible patient benefits / long-term business sustainability.
The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost.
The case example from Roche uses patient burden and protocol complexity in late-stage clinical development to demonstrate how this connection can be done in larger corporations and to emphasize patient engagement as a long-term growth driver and not just a short-term cost.
More specifically:
- Protocol design and executional practice, and the impact of current practices on protocol performance
- Framework, process and use cases for optimization of protocol performance through operationalization of patient preferences
- Direct impact on corporate goals like recruitment, retention and growth
For more information, go to DPHARMconference.com.
Related Podcasts
View All
How Pharma Is Adopting Generative AI Across Clinical Development
Tufts Center for Study of Drug Development on Evolving Clinical Trial Partnerships
Boehringer Ingelheim on Collaborations in Clinical Development for Launch Readiness
